Australian court suppresses report questioning effectiveness of complementary remedyBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7559.116-a (Published 13 July 2006) Cite this as: BMJ 2006;333:116
- Bob Burton
A Federal Court of Australia judge has granted an injunction sought by a complementary health company to temporarily suppress a report by a consumer watchdog group.
The report challenges claims that Tebonin, a product containing an extract of Ginkgo biloba, is an effective treatment for tinnitus.
In April 2006 Schwabe Pharma (Australia) launched a major marketing campaign in pharmacies, newspapers, and magazines promoting Tebonin for “tinnitus and vertigo relief.”
Tebonin contains an extract of Ginkgo biloba leaves called EGB761 and is made by the German company Dr Willmar Schwabe. On its website and in other …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial